Open access peer-reviewed chapter

Carbon-Based Materials (CBMs) for Determination and Remediation of Antimicrobials in Different Substrates: Wastewater and Infant Foods as Examples

Written By

Ahmed El-Gendy, Ahmed S. El-Shafie, Ahmed Issa, Saeed Al-Meer, Khalid Al-Saad and Marwa El-Azazy

Submitted: October 15th, 2019 Reviewed: February 13th, 2020 Published: August 19th, 2020

DOI: 10.5772/intechopen.91750

Chapter metrics overview

788 Chapter Downloads

View Full Metrics


The widespread use of antimicrobials within either a therapeutic or a veterinary rehearsal has resulted in a crisis on the long run. New strains of antimicrobial-resistant microorganisms have appeared. Contamination of water with pharmaceutically active materials is becoming a fact! and efficacy of wastewater treatment plants is a question. Adsorption is a promising technique for wastewater treatment. Carbon-based materials are among the most commonly used adsorbents for remediation purposes. Food production and commercialization are posing rigorous regulations. In this concern, almost all authoritarian societies are setting up standards for the maximum residue levels permissible in raw and processed food. Among these products is infant foods. The current trend is to use carbon-based and recycled from agricultural wastes, which can selectively remove target antimicrobials. Nanoparticles are among the most commonly used materials. With the enormous amount of data generated from an analytical process, there is a need for a powerful data processing technique. Factorial designs play an important role in not only minimalizing the number of experimental runs, and hence saving chemicals, resources, and reducing waste but also, they serve to improve the sensitivity and selectivity, the most important analytical outcomes.


  • pharmaceutically active materials (PhAMs)
  • wastewater treatment
  • adsorption
  • carbon-based materials (CBMs)
  • infant food
  • detection
  • factorial designs

1. Introduction

Drugs and pharmaceutically active materials (PhAMs) represent an enormous category of chemicals that include all materials with therapeutic effects (e.g., drugs that can be further classified according to their chemical structures, biological activities, and mechanism of action), cosmetics, supplementary and dietary products, personal care products (PCPs), X-rays contrast media, etc. Daily use of PhAMs is then becoming a fact. As per the Organization for Economic Co-operation and Development (OECD) report, in 2017, the expenditure on retail pharmaceuticals per capita was the highest in USA and averaged 564 $/person among the OECD countries [1].

It is noteworthy to mention that 75% of this amount was devoted to prescription drugs. With the increased awareness with health and health standards, the consumption of PhAMs is also escalating. As per FDA’s (USA Food and Drug Administration) Center for Drug Evaluation and Research’s (CDER) annual report, 59 novel drugs were approved in 2018, compared to 48 drugs in 2019. Of course, these approvals are associated with many new formulations being available for the consumer in the market [2, 3].

Representing a significant category of aquatic pollutants, PhAMs are usually released into the aquatic systems from different sources, including but not limited to: the effluents of the manufacturing sites and hospitals, illegal disposal, veterinary applications, and landfill leachate. The daily use by humans and the subsequent conversion of PhAMs into various metabolites with variable chemical structures is also a major source. The fate of these metabolites, and probably their parent drug compound, is usually the wastewater [4, 5, 6, 7, 8].

Antimicrobials (antibiotics, antifungals, antiseptics, antivirals, etc.) are also an enormous category of pharmaceuticals used mainly in the treatment and control of infectious diseases. Having unquestionable benefits for human and animal health, their use is becoming indispensable. However, nothing is absolute! The pervasive use of antimicrobials within either a therapeutic or a veterinary rehearsal (mainly antibiotics) especially in developing countries where medicine is usually dispensed as OTC (over the counter, non-prescription) drug has resulted in a crisis in the long run. Moreover, the excessive release of antibiotics into the surface and wastewater with ubiquitous concentrations reflects the magnitude of the problem [9]. New strains of antimicrobial-resistant microorganisms have appeared. These breeds are no longer responding to any medication, an issue that exaggerates the problem especially with the sluggish development of new drugs and therapeutics [10, 11, 12, 13].

Figure 1 shows a schematic representation of the subcategories of antibiotics and their fate in the environment.

Figure 1.

Schematic representation of categories of antibiotics and their routes in the environment.

Name of the antimicrobial * Indicative analytical method ** , *** Maximum acceptable method detection limit (ng/L)
Macrolide antibiotics
  • Erythromycin

  • Clarithromycin

  • Azithromycin

Metaflumizone LLE—LC-MS-MS
Amoxicillin SPE—LC-MS-MS 78
Ciprofloxacin SPE—LC-MS-MS 89

Table 1.

Some of the antimicrobials included in the watch-list of substances for Union-wide monitoring as set out in Article 8b of Directive 2008/105/EC.

CAS (Chemical Abstracts Service) and EU (European Union) numbers can be obtained from Ref. [30].

Extraction methods: LLE—liquid-liquid extraction; SPE—solid-phase extraction.

Analytical methods: GC–MS—Gas chromatography-mass spectrometry; LC-MS-MS—Liquid chromatography (tandem) triple quadrupole mass spectrometry.

Antimicrobials can be further classified according to their chemical structures into subcategories; for example, antibiotics can be classified into subclasses such as quinolones and fluoroquinolones, tetracyclines, aminoglycosides, β-lactams, sulfonamides, streptogramin antibiotics, nitroimidazoles, and macrolides [14]. Due to this variable chemical structure, removal of this category of pollutants is an intricate task. Several approaches exist in literature for the remediation of wastewater samples from antimicrobials and their metabolites. Similarly, many techniques were described to detect anti-infective agents in foods and dietary supplements.


2. Chapter taxonomy

Throughout the following subsections, the discussion will be focused on applications of carbon-based materials (CBMs) for the detection of antimicrobials in food products, especially baby foods, as well as the remediation of wastewaters from antimicrobials. Though the aim is to survey the use of CBMs in the literature as a removal approach, a comparison between CBMs and other materials/techniques used will be useful in terms of evaluating their removal efficiency. Special attention will be paid to the methods conducted via the use of factorial designs and response surface methodological approaches.


3. Pharmaceutically active materials (PhAMs) in water and wastewater: frequency, fate, health risks, regulatory concerns, and removal

3.1 Occurrences and fate

As previously mentioned, PhAMs intimidate the water systems from different sources. Contaminated water bodies included wastewater as well as drinking water. Reported concentrations were in the range of parts-per-trillion (ppt) up to parts-per-billion (ppb), and included locations all over the world [15, 16, 17, 18, 19, 20, 21]. Higher concentrations, up to μg/L, were also reported for more than 160 drug species and PhAMs [9, 22]. In a comprehensive review prepared by Verlicchi et al. [16], the risk quotient (RQ) of 51 PhAMs was screened and assessed. Out of the investigated PhAMs, it was found that 14 compounds represent a high risk to the environment. The list included seven antibiotics from different subclasses (erythromycin, azithromycin, clarithromycin, tetracycline, ofloxacin, amoxicillin, and sulfamethoxazole), representing 50% of the high-risk PhAMs. The reminder of the list included antipsychotics, lipid-regulating, and anti-inflammatory drugs. Yet, 19 PhAMs were of a medium risk, and this time the list included eight antimicrobials (penicillin G, sulfadiazine, cefotaxime, enoxacin, trimethoprim, doxycycline, roxithromycin, and metronidazole), representing around 42% of the reported list. For antimicrobials, concentrations ranged between 0.001 and 32 μg/L, with the highest absolute and highest average concentrations being reported for ofloxacin and sulfadiazine/ofloxacin, respectively. Antifungals also had their share and clotrimazole was reported with a concentration of 0.029 μg/L [16].

The presence of these concentrations in wastewater as well as drinking water is raising several apprehensions about the competency of wastewater treatment plants (WWTPs) and the implemented remediation techniques. These concerns might be resolved when it is comprehended that residues of undegradable PhAMs reach the WWTPs through the urban wastewater compilation structures. The positive point is that some of these compounds might be completely degradable and can be effectually removed; however, others, possessing variable chemical structures with different physical, biological, and chemical properties, may not.

These compounds being widely variable in terms of hydrophobicity, polarity, solubility, volatility, absorbability, and binding abilities, as well as biodegradability can get through to the WWTPs even at very low concentrations [23, 24, 25, 26]. The intricate task in removing PhAMs, therefore, stems from their properties. The majority of these materials possess acidic/basic functional groups, are of high polarity with high solubility, and cannot be easily degraded, or hydrolyzed. Yet, and in comparison to other contaminants (e.g., dyes/pigments, pesticides), PhAMs could be classified as persistent [27, 28].

Figure 1 shows a representation of the presence of antibiotics (human and veterinary) in the environment, and their routes until they reach the aquatic environments and WWTPs.

3.2 Health risks

The consequences of the existence of the PhAMs either in waste and drinking water or even in WWTPs is still indistinct. However, what is well understood is that the impact in the long run extends to human’s and animal’s health, the aquatic environment, and eventually the ecosystem. This effect is greatly dependent on the released dose of the PhAMs as well as their pharmacological effects. The issue becomes of concern when we know that the metabolites might be of a higher risk compared to the parent drug compound.

These effects and upon protracted exposure to PhAMs above the permissible limits include for example intoxication in human beings (e.g., the inundated enzyme-substrate relationship following long-term exposure to analgesics might result in elevated plasma concentrations and hence toxicity). Other adverse effects include somatic abnormalities, allergies, lung diseases, and hormonal disruption (e.g., in case of hormones, the adverse effects might instigate cancer following the destruction of DNA) [24, 29, 30, 31].

Moreover, the toxicity of the aquatic environment indirectly influences the human health. At the aquatic level, the metabolic mechanisms of aquatic microorganisms are affected. At the microbial level, microorganisms, upon prolonged exposure to anti-infectives, for example, become more tolerant and new strains, which cannot be cured using the conventional antimicrobials, are now in the scene. Influences include impaired reproduction, adversative effects on movement, and metabolism in mussels. Since PhAMs are not the only species released into the receiving aquatic bodies, adverse synergetic interactions between PhAMs and other contaminants should be expected [32, 33, 34].

3.3 Regulations and roles of regulatory bodies

The following few paragraphs will focus on the regulatory measures taken by the regulatory bodies and some countries to control the release of PhAMs, especially human drugs, in aquatic environments. Many countries have executed the environmental risk assessment (ERA) measures for the regulation of human PhAMs. Taking USA as an example, the National Environmental Policy Act of 1969 (NEPA) 21 C.F.R. 25.15, 40 C.F.R. 1508, necessitates all concerned organizations, for example, the U.S. EPA (Environmental Protection Agency) and the U.S. FDA, to implement the following measures:

  • Assess the environmental influences of their actions,

  • Perform an environmental assessment (EA),

  • Create an environmental impact statement (EIS).

Consequently, any application to file a new drug to the US FDA requires the applicant to submit an EA or requires an entitlement for categorical exclusion. The latter would be approved in case the filed substance will not increase the concentration of an “active moiety”; or it will increase the concentration of this moiety, but the estimated concentration of this moiety as it reaches the aquatic body (entrance point) is below 1 ppb; or the filed material will neither change the distribution of the substance, nor its metabolites or degradation products [35]. In Canada, however, a priority substance list (PSL) has been founded and priority is given to the assessment of the toxicity of the PhAMs [36, 37, 38].

As per US FDA guidelines, and in order to estimate the expected introduction concentration (EIC) of a substance at the point of entry to the aquatic body, the following equation should be used:

EIC Aquatic ppb = A B C D E1


A is the amount produced of the PhAM annually—as an active moiety—in kilograms and designated for direct use;

B is the L−1/ day entering the publicly owned treatment works (POTWs);

C is the conversion factor (1 year/365 days); and

D is the conversion factor (109 μg/kg)

This equation was established assuming the following:

  • No metabolism is taking place,

  • All PhAMs manufactured annually are consumed and enter the POTWs,

  • The use of the produced PhAMs happens thru the US and depends on the population and quantity of wastewater produced.

The European Union (EU), and on the other hand, has created two lists: one is a priority list, which includes 45 PhAMs where the environmental quality standards (EQS) have to be held in the highest regard for the disposal of these materials into the aquatic environments. The other list is a “watch-list” that compromises eight PhAMs, for which the risk to the aquatic environment needs to be investigated and verified [39]. The second list included antimicrobials, mainly antibiotics (azithromycin). Two other antibiotics, amoxicillin and ciprofloxacin, were also included in the same list but with different justifications. As per the commission, new “eco-toxicological” data were obtained for clarithromycin and azithromycin. Table 1 shows the antimicrobials included in the watch-list, their analytical method of detection, and the maximum acceptable method detection limit (ng/L).

3.4 Water and wastewater treatment approaches

3.4.1 Classification of remediation approaches

Surveying the literature shows that different approaches have been reported for remediation of water and wastewater from PhAMs [24]. In general, wastewater treatment technologies can be categorized into chemical (e.g., ion exchange, chlorination, coagulation, ozonation, photo- and chemical oxidation); physical (e.g., membrane separation, and adsorption); and biological (e.g., biodegradation, membrane bioreactor, and enzyme bioreactor) approaches. Sometimes, combinational approaches are used as a series of treatment steps [24, 38, 39, 40, 41, 42, 43, 44, 45]. Each of these approaches has its pros and cons. For example, chemical and physical approaches, unless being coupled to experimental design and response surface methodological approaches, would result in the generation of toxic byproducts, and the consumption of chemicals and solvents as well as time and resources. Overall, these techniques will not be green or ecofriendly. Figure 2 shows a classification of the commonly used approaches in wastewater treatment.

Figure 2.

Classification of wastewater treatment technologies.

3.4.2 Adsorption as a remediation approach

As previously mentioned, removal of PhAMs in WWTPs might be inadequate and occurs partially. Implementing the traditional remediation techniques, the removal of antibiotics was incomplete (e.g., removal of β-lactams was achieved with 17–43% efficiency, macrolides with 40–46% efficiency, sulfonamides with 66–90% efficiency, and tetracyclines with 66–90% efficiency) [46]. Adsorption as a physical/chemical remediation methodology is a versatile technique that has been extensively used in water and wastewater treatment from almost all types of contaminants (dyes, heavy metals, PhAMs, etc.) [6, 7, 8, 41, 43, 46, 47, 48, 49, 50, 51].

As an approach, adsorption offers several advantages, mainly the availability of candidate adsorbents at almost no cost, easy application on the large scale with no toxic byproducts being generated, and most importantly, reasonable competency. Moreover, adsorption can be used as a removal approach following biological or chemical treatments in WWTPs. Several materials have been reported in literature as adsorbents. These adsorbents might be naturally occurring (e.g., carbon adsorbents recycled from agricultural waste products) [47, 48, 49, 50, 51], or synthetic (e.g., microporous and mesoporous carbons synthesized using Y zeolite and synthesized mesoporous silica as hard templates) [52]. Various adsorbents were reported in literature for the removal of antibiotics [53]; for example, carbonaceous materials [54], polymeric resins [55], chitosan [56], mesoporous materials [52], and molecularly imprinted polymers (MIPs) [57]. In the following subsections, the focus will be on carbon-based materials and their subcategories that are commonly used in the removal of antimicrobials.

3.4.3 Carbon-based materials (CBMs) for water and wastewater treatment

Possessing high surface area, pore size distribution, and pore volume, surface properties that enable strong interaction with the adsorbate, carbonaceous materials are among the most widely used and investigated adsorbents. In the following subsections, application of activated carbons (AC), graphene, carbon xerogels, and carbon nanotubes (CNTs), see Figure 2, in the treatment of water and wastewater from contaminants will be thoroughly discussed. Activated carbons (ACs)

Activated carbon (AC) is generally a porous solid material with high surface area. With a high extent of microporosity, AC is a contemporaneous adsorbent that is widely used in water treatment on a large scale. According to the IUPAC classification, three types of materials can be recognized depending on the pore diameter: (1) microporous (pores ˂ 2 nm diameter), (2) mesoporous (pores 2–50 nm diameter), and (3) macroporous (pores ˃ 50 nm diameter) [58]. Activated carbon is an example of mesoporous materials, which is basically composed of a non-constant carbon framework. In reality, both micro- and mesopores exist in AC depending on the synthetic conditions.

As mentioned, AC can be obtained from agro-waste, carbonization at low temperature, and activation (physical “PA” or chemical “CA” depending on the temperature at which the activation/carbonization was conducted, and the experimental conditions where PA is usually conducted at anaerobic conditions compared to the use of inert gas in case of CA) [47, 48, 49, 50, 51, 53]. Adsorption capacity and efficiency are greatly dependent on the activation procedure followed and the nature of the raw material. Though CA takes place over a short period of time compared to PA, due to the usage of chemicals, CA might not be an ecofriendly approach [59, 60].

Treatment of AC using different approaches and with the purpose of increasing its adsorption efficiency for antimicrobials or even using it without activation has been the subject of lots of investigations. Treatment procedures included loading of magnetite nanoparticles, where for example, powdered date pits (DPs) were treated with a mixture of ferric and ferrous with a ratio of 2:1, followed by stirring at 60°C for 3 h, then neutralization using 4 M NaOH till pH 12. The mixture was washed with water several times, with methanol four times and then left to evaporate. Figure 3 shows a picture for DPs before and after magnetization. Prepared AC was used for the removal of enrofloxacin and difloxacin from water samples. Other activation techniques included treatment with NaOH for the removal of tetracycline [61], H3PO4 and H4P2O7-AC for the removal of ciprofloxacin [62], composites for the removal of tetracycline [63], and sulfamethoxazole [64]. Untreated AC was also applied for the removal of antibiotics; for example, non-AC produced by pyrolysis of primary paper mill sludge was used for the removal of sulfamethoxazole [65] and tetracyclines [66].

Figure 3.

Date pits (DPs) (A) before and (B) after loading of magnetite. Picture was taken in our laboratory at Qatar University. Carbon nanotubes (CNTs)

First discovered in 1991, CNTs have become a target of hundreds of investigations. Representing an enormous transition in the field of nano-products, CNTs have seen an escalating interest in applications as well as investment. With extraordinary physicochemical properties, and feasibility of surface modification, CNTs are a trap for many environmental pollutants. Compared to the discrete structure of ACs, CNTs possess a more compact and well-defined structure. Three types of CNTs are now known: single-walled carbon nanotubes (SWCNTs), double-walled carbon nanotubes (DWCNTs), and multi-walled carbon nanotubes (MWCNTs). As their name implies, MWCNTs, unlike SWCNTs, are basically formed of cylinders arranged coaxially with the graphitic shells being alienated at a space of 0.34 nm, and a diameter of 1 nm. Therefore, the aspect ratio of the cylinder usually surpasses 105 and the CNTs are usually said to be highly directionally dependent or anisotropic. This feature, in addition to the noticeable chirality of the carbon atoms and their possible variable arrangements around the perimeter of the cylinder, the hollow structure with multiple adsorption sites, represents that of an ideal adsorbent [67, 68, 69, 70]. Figure 4 shows the possible adsorption sites in a CNT:

  1. The external sites: located on the outside surface of each CNT;

  2. The internal sites: the interior of individual CNT;

  3. The interstitial sites: located between the nanotubes;

  4. The furrows: located across the peripheral intersection of two adjacent CNTs.

Figure 4.

(A) SWCNTs and (B) MWCNTs. The inset shows the possible adsorption sites.

Applications of CNTs in the removal of antimicrobials has seen a major progress in the past few years. Untreated SWCNTs were used to remove tetracycline, sulfamethoxazole, and ciprofloxacin, oxytetracycline [71, 72, 73, 74]. SWCNTs refluxed with 70% HNO3 were used for the removal of triclosan [75]. Pristine MWCNTs were used for the removal of roxarsone [76]. Functionalization with carboxylic and hydroxyl moieties facilitated the removal of sulfapyridine [77]. Graphene-based materials

Graphene, graphene oxide (GO), and reduced graphene oxides (rGOs) are attracting a great deal of attention nowadays. Graphene is a 2D sheet in which the Sp2 -hybridized carbon atoms are arranged as a monolayer. With a large surface area, graphene can adsorb aquatic PhAMs via van der Waals or π-π electronic interactions [46, 78]. Since majority of antibiotics possess one or more cyclic component, they can be feasibly adsorbed by graphene via π-π interaction. Ciprofloxacin is among the antibiotics that have been removed using GS (graphene-soy gel) bio-composites [79]. GO was used to remove levofloxacin from aqueous solutions [80]. rGOs were similarly applied to remove sulfapyridine and sulfathiazole [81].


4. PhAMs in infant food: occurrence, health risks, regulations, and determination

4.1 Occurrence, health risks, and regulatory issues

Three categories of infant foods can be recognized: (1) infant formulas (0–6 months), (2) follow-on formulas (6–12 months), and (3) growth formulas (different ages after baby’s first year and dependent on child’s age). The composition of these formulas is variable and is dependent on the infant’s age and nutritional needs of this age. Source of these formulas is therefore variable. Bovine milk is a major source for these formulas. Therefore, it is indispensable to ensure that these formulas are veterinary-drugs free!

The increasing understanding of the assembly of the food chain and the probability of infection of human with these resilient microorganisms either directly or via the food chain has explained largely the spread of these species. Therefore, the process of food production and commercialization is posing more rigorous regulations nowadays. In this regard, different societies, for example Food and Drug Administration (US FDA), European Union (EU), World Health Organization (WHO) in collaboration with Food and Agriculture Organization of the United Nations (FAO) creating the FAO/WHO Codex Alimentarius Commission (CAC), are setting up standards for the maximum residue levels (MRLs) permissible in raw and processed food products of animal or poultry origin. Yet, any food product that would conform to these criteria and the preceding risk assessments cannot be banned by countries of the World Trade Organization (WTO) [82, 83, 84, 85, 86].

Infant foods, in specific, should be monitored with a kind of scrupulousness either statutory or non-statutory. The main apprehension is that this food is to be offered to an age group that is the most susceptible for microbial infections and the chance of spread of resistant microorganisms becomes more likely. As per EU council regulation No. 2377/90, the MRL extends to include not only the intact drugs, but their degradation products as well as their metabolites. While the MRLs are well defined for a variety of baby foods, the situation is different for meat-, milk-, poultry-based infant foods, where the EU council is implementing the zero-tolerance policy; that is, the presence of such drugs in the said foods is totally banned. Existence of such a policy necessitates the presence of a sensitive analytical technique that can determine suspected drugs at even minute concentrations [86, 87].

4.2 Determination of antimicrobials in infant foods

Few methods exist in literature for the determination of antimicrobials in infant foods with major attention being directed to fluoroquinolones and tetracyclines, few antifungals, antiseptics, and antivirals. Techniques used ranged from pressurized liquid extraction followed by solid phase extraction (SPE) and LC-fluorescence detector analysis to ultra-high-performance liquid chromatography hyphenated to tandem mass spectrometry (UHPLC-MS/MS) and salting-out assisted liquid-liquid extraction (LLE) coupled to UHPLC-MS/MS [88, 89, 90, 91, 92].

With the progression in analytical method development, the current trend is to use miniaturized materials, which can selectively remove the target antimicrobial. Nanoparticles (NPs) either functionalized or non-functionalized, MWCNTs, molecularly imprinted polymers (MIPs), and graphene are among the most commonly used materials. Magnetic nanoparticles (MNPs) in particular and with their large surface area, and hence the swiftness of sorption, offer a great advantage in sample treatment [93, 94]. Surveying the literature shows that applications of CBMs in sample treatment are almost absent. In one of the investigations [95], the Zr-Fe-CMNPs composites were studied for sample pretreatment. It was shown that coating of the Zr-Fe MNPs with carbon increased elution efficiency of the studied fluoroquinolones, and therefore was used for the determination of fleroxacin, norfloxacin, and ofloxacin in meat-based baby food samples.


5. Multivariate analysis

Several parameters affect the adsorption of PhAMs either from wastewater or from foods. For example, parameters such as pH, contact time, adsorbent dose, initial adsorbate concentration, and ionic strength can affect adsorption efficiency of studied adsorbents [47, 48, 49, 50, 51].

Yet, very few of the techniques reported in literature implemented chemometrics or factorial designs as an approach and the regular one-variable-at-time (OVAT) approach is still used. In such an approach, only one variable is investigated at a time, with almost no idea about factorial interactions and no idea on how to deal with multiple-response variables concurrently. With the enormous amount of data generated from an analytical process, the need for a powerful data processing technique is needed. Chemometrics plays an important role not only in minimalizing the number of experimental runs, and hence saving chemicals, resources, and reducing waste but also in serving to improve the sensitivity and selectivity of the methods, the most important analytical outcomes [47, 48, 49, 50, 51, 96, 97, 98, 99].

As a vision, Green Analytical Chemistry (GAC) adopts 12 principles that serve to compromise between the quality of an analytical process and the conservation of environment. Achieving such a settlement is an intricate task! Using chemometrics is one aspect of such an arrangement and ensuring a sustenance of the highest safety standards—both in water and wastewater remediation and in the production of infant foods—is another aspect.

Design of Experiments (DoE) as a multivariate approach is used to screen and then optimize the experimental conditions. The design usually entails two phases: screening (where all variables that might affect the process are investigated at wider levels), then optimization (where variables that were proved to be statistically significant from phase I are re-tested at narrower levels). Both phases are accompanied by statistical analysis using analysis of variance (ANOVA) [99].

In one of the investigations, a method based on pressurized liquid (PLE) and LC with fluorescence detection (LC-FLD) was used for the determination of residues of fluoroquinolones in baby foods. Factorial design was implemented in two phases. In the screening rehearsal, a fractional-factorial design was adopted to screen the impact of four parameters on the extraction process. Statistically significant variables as per ANOVA were further optimized using the face-centered central composite design [89, 100]. Applications of other designs were also reported [101].


6. Conclusions

The literature is rich with hundreds of articles that investigate the removal of antimicrobials from water and wastewater samples. Investigations that entail the usage of CBMs such as ACs, CNTs, and the graphene family, which possess unique physicochemical properties and most importantly a high surface area, are the most prevailing. Yet, and on the other hand, very few investigations on the determination of antimicrobials in baby foods, an important concern, are available in literature. Usage of CBMs in such a rehearsal is almost absent. All in all, removal of antimicrobials from wastewater and their determination in baby foods are usually affected by a number of variables. The common approach found in literature is the one based on the investigation of one-factor-at-a-time (OFAT). Application of chemometrics is still not as expected.



This work was made possible by Qatar University Internal Student Grant [QUCG-CAS-19/20-3] from Qatar University. The statements made herein are solely the responsibility of the authors.


Conflict of interest

The authors declare no conflict of interest.


  1. 1. OECD. Health at a Glance 2019: OECD Indicators, OECD Publishing, Paris [Internet]. 2019. Available from:
  2. 2. Impact Innovation Predictability Access. FDA’s Center for Drug Evaluation and Research [Internet]. 2020. Available from:
  3. 3. Rahmah AU, Harimurti S, Omar AA, Murugesan T. Optimization of oxytetracycline degradation inside UV/H2O2 reactor using box-Behnken experimental design. Journal of Applied Sciences. 2012;12:1154-1159. DOI: 10.3923/jas.2012.1154.1159
  4. 4. Singh KP, Singh AK, Singh UV, Verma P. Optimizing removal of ibuprofen from water by magnetic nanocomposite using box-Behnken design. Environmental Science and Pollution Research. 2012;19:724-738. DOI: 10.1007/s11356-011-0611-4
  5. 5. Aa N, Kommer GJ, Van Montfoort J, Versteegh J. Demographic projections of future pharmaceutical consumption in the Netherlands. Water Science and Technology. 2011;63:825-831. DOI: 10.2166/wst.2011.120
  6. 6. Avcı A, Inci I, Baylan N. Adsorption of ciprofloxacin hydrochloride on multiwall carbon nanotube. Journal of Molecular Structure. 2020;1206:127711. DOI: 10.1016/j.molstruc.2020.127711
  7. 7. Yu F, Sun S, Han S, Zheng J, Ma J. Adsorption removal of ciprofloxacin by multi-walled carbon nanotubes with different oxygen contents from aqueous solutions. Chemical Engineering Journal. 2016;285:588-595. DOI: 10.1016/j.cej.2015.10.39
  8. 8. Carmosini N, Lee LS. Ciprofloxacin sorption by dissolved organic carbon from reference and bio-waste materials. Chemosphere. 2009;77:813-820. DOI: 10.1016/j.chemosphere.2009.08.003
  9. 9. Larsson DGJ, de Pedro C, Paxeus N. Effluent from drug manufactures contains extremely high levels of pharmaceuticals. Journal of Hazardous Materials. 2007;148:751-755. DOI: 10.1016/j.jhazmat.2007.07.008
  10. 10. Salmon GPC, Welch M. Antibiotic resistance: Adaptive evolution. The Lancet. 2008;372:S97-S103. DOI: 10. 1016/S0140-6736(08)61888-7
  11. 11. Kemper N. Veterinary antibiotics in the aquatic and terrestrial environment. Ecological Indicators. 2008;8:1-13. DOI: 10.1016/j.ecolind.2007.06.002
  12. 12. WHO. Global strategy for containment of antimicrobial resistance, Executive summary 2001, World Health Organization (WHO), Geneva; 2001. Available from:
  13. 13. Meeting on Antimicrobial Resistance, Brussels. 2008. Available from: en.htm
  14. 14. Ullah H, Ali S. Classification of anti-bacterial agents and their functions. In: Kumavath RN, editor. Antibacterial Agents. IntechOpen; 2017. DOI: 10.5772/intechopen.68695. Available from:
  15. 15. Gumbi BP, Moodley B, Birungi G, Ndungu PG. Detection and quantification of acidic drug residues in South African surface water using gas chromatography mass spectrometry. Chemosphere. 2017;168:1042-1050. DOI: 10.1016/j.chemosphere.2016.10.105
  16. 16. Verlicchi P, Al Aukidy M, Zambello E. Occurrence of pharmaceutical compounds in urban wastewater: Removal, mass load and environmental risk after a secondary treatment—A review. Science of the Total Environment. 2012;429:123-155. DOI: 10.1016/j.scitotenv.2012.04.028
  17. 17. Sarmah AK, Meyer MT, Boxall ABA. A global perspective on the use, sales, exposure pathways, occurrence, fate and effects of veterinary antibiotics (VAs) in the environment. Chemosphere. 2006;65:725-759. DOI: 10.1016/j.chemosphere.2006.03.026
  18. 18. Couto CF, Lange LC, Amaral MCS. Occurrence, fate and removal of pharmaceutically active compounds (PhACs) in water and wastewater treatment plants—A review. Journal of Water Process Engineering. 2019;32:100927. DOI: 10.1016/j.jwpe.2019.100927
  19. 19. Valcarcel Y, Alonso SG, Rodríguez-Gil JL, Castano A, Montero JC, Criado-Alvarez JJ, et al. Seasonal variation of pharmaceutically active compounds in surface (Tagus River) and tap water (Central Spain). Environmental Science and Pollution Research. 2013;20:1396-1412. DOI: 10.1007/s11356-012-1099-2
  20. 20. Watkinson AJ, Murby EJ, Kolpin DW, Costanzo SD. The occurrence of antibiotics in an urban watershed: From wastewater to drinking water. The Science of the Total Environment. 2009;407:2711-2723. DOI: 10.1016/j.scitotenv.2008.11.059
  21. 21. Net S, Rabodonirin S, Sghaier RB, Dumoulin D, Chbi C, Tlili I, et al. Distribution of phthalates, pesticides and drug residues in the dissolved, particulate and sedimentary phases from transboundary rivers (France-Belgium). The Science of the Total Environment. 2015;521:152-159. DOI: 10.1016/j.scitotenv.2015.03.087
  22. 22. Hernández F, Ibáñez M, Bade R, Bijlsma L, Sancho JV. Investigation of pharmaceuticals and illicit drugs in waters by liquid chromatography-high-resolution mass spectrometry. TrAC Trends in Analytical Chemistry. 2014;63:140-157. DOI: 10.1016/j.trac.2014.08.003
  23. 23. Bell KY, Bandy J, Beck S, Keen O, Kolankowsky N, Parker AM, et al. Emerging pollutants – Part II: Treatment. Water Environment Research. 2012;84:1909-1940. DOI: 10.1002/wer.1233
  24. 24. Taheran M, Brar SK, Verma M, Surampalli RY, Zhang TC, Valero JR. Membrane processes for removal of pharmaceutically active compounds (PhACs) from water and wastewaters. The Science of the Total Environment. 2016;547:60-77. DOI: 10.1016/j.scitotenv.2015.12.139
  25. 25. Ziylan A, Ince NH. The occurrence and fate of anti-inflammatory and analgesic pharmaceuticals in sewage and fresh water: Treatability by conventional and non conventional processes. Journal of Hazardous Materials. 2011;187:24-37. DOI: 10.1016/j.jhazmat.2011.01.057
  26. 26. Le Minh N, Khan SJ, Drewes JE, Stuetz RM. Fate of antibiotics during municipal water recycling treatment processes. Water Research. 2010;44:4295-4323. DOI: 10.1016/j.watres.2010.06.020
  27. 27. Behera SK, Kim HW, Oh JE, Park HS. Occurrence and removal of antibiotics, hormones and several other pharmaceuticals in wastewater treatment plants of the largest industrial city of Korea. The Science of the Total Environment. 2011;409:4351-4360. DOI: 10.1016/j.scitotenv.2011.07.015
  28. 28. Daneshkhah M, Hossaini H, Malakootian M. Removal of metoprolol from water by sepiolite-supported nanoscale zero-valent iron. Journal of Environmental Chemical Engineering. 2017;5:3490-3499. DOI: 10.1016/j.jece.2017.06.040
  29. 29. Martin J, Camacho-Munoz D, Santos JL, Aparicio I, Alonso E. Occurrence of pharmaceutical compounds in wastewater and sludge from wastewater treatment plants: Removal and ecotoxicological impact of wastewater discharges and sludge disposal. Journal of Hazardous Materials. 2012;239:40-47. DOI: 10.1016/j.jhazmat.2012.04.068
  30. 30. Khetan SK, Collins TJ. Human pharmaceuticals in the aquatic environment: A challenge to green chemistry. Chemical Reviews. 2007;107:2319-2364. DOI: 10.1021/cr020441w
  31. 31. Yasuda MT, Sakakibara H, Shimoi K. Estrogen-and stress-induced DNA damage in breast cancer and chemoprevention with dietary flavonoid. Genes and Environment. 2017;39:1-9. DOI: 10.1186/s41021-016-0071-7
  32. 32. Ebele AJ, Abdallah MA, Harrad S. Pharmaceuticals and personal care products (PPCPs) in the freshwater aquatic environment. Emerging Contaminant. 2017;3:1-16. DOI: 10.1016/j.emcon.2016.12.004
  33. 33. Boyer EW. Management of opioid analgesic overdose. The New England Journal of Medicine. 2012;367:146-155. DOI: 10.1056/NEJMra1202561
  34. 34. Carbajo JB, Petre AL, Rosal R, Herrera S, Leton P, Garcia-Calvo E, et al. Continuous ozonation treatment of ofloxacin: Transformation products, water matrix effect and aquatic toxicity. Journal of Hazardous Materials. 2015;292:34-43. DOI: 10.1016/j.jhazmat.2015.02.075
  35. 35. U.S. FDA CDER/CBER. Guidance for Industry Environmental Assessment of Human Drug and Biologics Applications [Internet]. 1998. Available from: [Accessed: 28 January 2020]
  36. 36. Environment Canada. Overview of the Existing Substances Program [Internet]. 2007. Available from: [Accessed: 28 January 2020]
  37. 37. Environment Canada. The Canadian Environmental Protection Act, 1999 and the Assessment of New Substances [Internet]. 2015b. Available from: [Accessed: 28 January 2020]
  38. 38. Geaniyu SO, Hullebusch EDV, Cretin M, Esposito G, Oturan MA. Coupling of membrane filtration and advanced oxidation processes for removal of pharmaceutical residues: A critical review. Separation and Purification Technology. 2015;156(Part 3):891-914. DOI: 10.1016/j.seppur.2015.09.059
  39. 39. Commission Implementing Decision (EU), 2018/840 Of 5 June 2018 Establishing a Watch List of Substances for Union-wide Monitoring in the Field of Water Policy Pursuant to Directive 2008/105/EC of the European Parliament and of the Council and Repealing Commission Implementing Decision (EU) 2015/495 (notified Under Document C); 2018. p. 3362
  40. 40. Madhavan J, Grieser F, Ashokkumar M. Combined advanced oxidation processes for the synergistic degradation of ibuprofen in aqueous environments. Journal of Hazardous Materials. 2010;178:202-208. DOI: 10.1016/j.jhazmat.2010.01.064
  41. 41. Pei M, Zhang B, He Y, Su J, Gin K, Lev O, et al. State of the art of tertiary treatment technologies for controlling antibiotic resistance in wastewater treatment plants. Environment International. 2019;131:105026. DOI: 10.1016/j.envint.2019.105026
  42. 42. Bagheri H, Afkhami A, Noroozi A. Removal of pharmaceutical compounds from hospital wastewaters using nanomaterials: A review. Analytical and Bioanalytical Chemistry Research. 2016;3:1-18. DOI: 10.22036/abcr.2016.12655
  43. 43. Carabineiro S, Thavorn-Amornsri T, Pereira M, Serp P, Figueiredo J. Comparison between activated carbon, carbon xerogel and carbon nanotubes for the adsorption of the antibiotic ciprofloxacin. Catalysis Today. 2012;186:29-34. DOI: 10.1016/j.cattod.2011.08.020
  44. 44. Wang C-J, Li Z, Jiang W-T, Jean J-S, Liu C-C. Cation exchange interaction between antibiotic ciprofloxacin and montmorillonite. Journal of Hazardous Materials. 2010;183:309-314. DOI: 10.1016/j.jhazmat.2010.07.025
  45. 45. Sun SP, Hatton TA, Chung T-S. Hyperbranched polyethyleneimine induced cross-linking of polyamide-imide nanofiltration hollow fiber membranes for effective removal of ciprofloxacin. Environmental Science & Technology. 2011;45:4003-4009. DOI: 10.1021/es200345q
  46. 46. Peng B, Chen L, Que C, Yang K, Deng F, Deng X, et al. Adsorption of antibiotics on graphene and biochar in aqueous solutions induced by π-π interactions. Scientific Reports. 2016;6:31920. DOI: 10.1038/srep31920
  47. 47. El-Azazy M, Dimassi S, El-Shafie AS, Issa AA. Bio-waste Aloe vera leaves as an efficient adsorbent for titan yellow from wastewater: Structuring of a novel adsorbent using Plackett-Burman factorial design. Applied Sciences. 2019;9:1-20. DOI: 10.3390/app9224856
  48. 48. El-Azazy M, El-Shafie AS, Ashraf A, Issa AA. Eco-structured Biosorptive removal of basic Fuchsin using pistachio nutshells: A definitive screening design—Based approach. Applied Sciences. 2019;9:1-19. DOI: 10.3390/app9224855
  49. 49. Al-Saad K, El-Azazy M, Issa AA, Al-Yafei A, El-Shafie AS, Al-Sulaiti M, et al. Recycling of date pits into a green adsorbent for removal of heavy metals: A fractional factorial design-based approach. Frontiers in Chemistry. 2019;7-552:1-16. DOI: 10.3389/fchem.2019.00552
  50. 50. El-Azazy M, Kalla RN, Issa AA, Al-Sulaiti M, El-Shafie AS, Shomar B, et al. Pomegranate peels as versatile adsorbents for water purification: Application of box–Behnken design as a methodological optimization approach. Environmental Progress & Sustainable Energy. 2019;38:1-12. DOI: 10.1002/ep.13223
  51. 51. El-Azazy M, El-Shafie AS, Issa AA, Al-Sulaiti M, Al-Yafie J, Shomar B, et al. Potato peels as an adsorbent for heavy metals from aqueous solutions: Eco-structuring of a green adsorbent operating Plackett-Burman design. Journal of Chemistry. 2019;2019:1-14. DOI: 10.1155/2019/4926240
  52. 52. Ji L, Liu F, Xu Z, Zheng S, Zhu D. Adsorption of pharmaceutical antibiotics on template-synthesized ordered micro-and mesoporous carbons. Environmental Science & Technology. 2010;44:3116-3122. DOI: 10.1021/es903716s
  53. 53. Yu F, Li Y, Han S, Ma J. Adsorptive removal of antibiotics from aqueous solution using carbon materials. Chemosphere. 2016;153:365-385. DOI: 10.1016/j.chemosphere.2016.03.083
  54. 54. Ahmed MJ, Theydan SK. Adsorption of cephalexin onto activated carbons from Albizia lebbeck seed pods by microwave-induced KOH and K2CO3 activations. Chemical Engineering Journal. 2012;211:200-207. DOI: 10.1016/j.cej.2012.09.089
  55. 55. Dutta M, Dutta N, Bhattacharya K. Aqueous phase adsorption of certain β-lactam antibiotics onto polymeric resins and activated carbon. Separation and Purification Technology. 1999;16:213-224. DOI: 10.1016/S1383-5866(99)00011-8
  56. 56. Adriano W, Veredas V, Santana C, Gonçalves L. Adsorption of amoxicillin on chitosan beads: Kinetics, equilibrium and validation of finite bath models. Biochemical Engineering Journal. 2005;27:132-137. DOI: 10.1016/j.bej.2005.08.010
  57. 57. Xu L, Pan J, Dai J, Li X, Hang H, Cao Z, et al. Preparation of thermal- responsive magnetic molecularly imprinted polymers for selective removal of antibiotics from aqueous solution. Journal of Hazardous Materials. 2012;233:48-56. DOI: 10.1016/j.jhazmat.2012.06.056
  58. 58. Rouquerol J, Avnir D, Fairbridge CW, Everett DH, Haynes JM, Pernicone N, et al. Recommendations for the characterization of porous solids (technical report). Pure and Applied Chemistry. 1994;66:1739-1758
  59. 59. Wigmans T. Industrial aspects of production and use of activated carbons. Carbon. 1989;27:13-22. DOI: 10.1016/0008-6223(89)90152-8
  60. 60. Holden M. Manufacture and uses of activated carbon. Effluent & Water Treatment Journal. 1982;22:27-46
  61. 61. Martins AC, Pezoti O, Cazetta AL, Bedin KC, Yamazaki DA, Bandoch GF, et al. Removal of tetracycline by NaOH activated carbon produced from macadamia nut shells: Kinetic and equilibrium studies. Chemical Engineering Journal. 2015;260:291-299. DOI: 10.1016/j.cej.2014.09.017
  62. 62. Sun Y, Yue Q , Gao B, Huang L, Xu X, Li Q. Comparative study on characterization and adsorption properties of activated carbons with H3PO4 and H4P2O7 activation employing Cyperus alternifolius as precursor. Chemical Engineering Journal. 2012a;181:790-797. DOI: 10.1016/j.cej.2011.11.098
  63. 63. Shao L, Ren Z, Zhang G, Chen L. Facile synthesis, characterization of a MnFe2O4/activated carbon magnetic composite and its effectiveness in tetracycline removal. Materials Chemistry and Physics. 2012;135:16-24. DOI: 10.1016/j.matchemphys.2012.03.035
  64. 64. Akhtar J, Amin NS, Aris A. Combined adsorption and catalytic ozonation for removal of sulfamethoxazole using Fe2O3/CeO2 loaded activated carbon. Chemical Engineering Journal. 2011;170:136-144. DOI: 10.1016/j.cej.2011.03.043
  65. 65. Calisto V, Ferreira CI, Oliveira JA, Otero M, Esteves VI. Adsorptive removal of pharmaceuticals from water by commercial and waste-based carbons. Journal of Environmental Management. 2015;152:83-90. DOI: 10.1016/j.jenvman.2015.01.019
  66. 66. Choi KJ, Kim SG, Kim SH. Removal of tetracycline and sulfonamide classes of antibiotic compound by powdered activated carbon. Environmental Technology. 2008;29:333-342. DOI: 10.1080/09593330802102223
  67. 67. Iijima S. Helical microtubules of graphitic carbon. Nature. 1991;354:56-58. DOI: 10.1038/354056a0
  68. 68. Pan B, Xing BS. Adsorption mechanisms of organic chemicals on carbon nanotubes. Environmental Science & Technology. 2008;42:9005-9013. DOI: 10.1021/es801777n
  69. 69. Iijima S, Ichihashi T. Single-shell carbon nanotubes of 1-nm diameter. Nature. 1993;363:603-605. DOI: 10.1038/363603a0
  70. 70. Rena X, Chena C, Nagatsu M, Wang X. Carbon nanotubes as adsorbents in environmental pollution management: A review. Chemical Engineering Journal. 2011;170:395-410. DOI: 10.1016/j.cej.2010.08.045
  71. 71. Ji L, Chen W, Duan L, Zhu D. Mechanisms for strong adsorption of tetracycline to carbon nanotubes: A comparative study using activated carbon and graphite as adsorbents. Environmental Science & Technology. 2009;43:2322-2327. DOI: 10.1021/es803268b
  72. 72. Kim H, Hwang YS, Sharma VK. Adsorption of antibiotics and iopromide onto single-walled and multi-walled carbon nanotubes. Chemical Engineering Journal. 2014;255:23-27. DOI: 10.1016/j.cej.2014.06.035
  73. 73. Peng H, Pa B, Wu M, Liu Y, Zhang D, Xing B. Adsorption of ofloxacin and norfloxacin on carbon nanotubes: Hydrophobicity-and structure-controlled process. Journal of Hazardous Materials. 2012;233:89-96. DOI: 10.1016/j.jhazmat.2012.06.058
  74. 74. Ncibi MC, Sillanpää M. Optimized removal of antibiotic drugs from aqueous solutions using single, double and multi-walled carbon nanotubes. Journal of Hazardous Materials. 2015;298:102-110. DOI: 10.1016/j.jhazmat.2015.05.025
  75. 75. Cho H-H, Huang H, Schwab K. Effects of solution chemistry on the adsorption of ibuprofen and triclosan onto carbon nanotubes. Langmuir. 2011;27:12960-12967. DOI: 10.1021/la202459g
  76. 76. Hu J, Tong Z, Hu Z, Chen G, Chen T. Adsorption of roxarsone from aqueous solution by multi-walled carbon nanotubes. Journal of Colloid and Interface Science. 2012;377:355-361. DOI: 10.1016/j.jcis.2012.03.064
  77. 77. Tian Y, Gao B, Morales VL, Chen H, Wang Y, Li H. Removal of sulfamethoxazole and sulfapyridine by carbon nanotubes in fixed-bed columns. Chemosphere. 2013;90:2597-2605. DOI: 10.1016/j.chemosphere.2012.11.010
  78. 78. Zhuang Y, Yu F, Ma J, Chen J. Graphene as a template and structural scaffold for the synthesis of a 3D porous bio-adsorbent to remove antibiotics from water. RSC Advances. 2015;5:27964-27969. DOI: 10.1039/c4ra12413h
  79. 79. Zhuang Y, Yu F, Ma J, Chen J. Adsorption of ciprofloxacin onto graphene-soy protein biocomposites. New Journal of Chemistry. 2015;39:3333-3336. DOI: 10.1039/C5NJ00019J
  80. 80. Dong S, Sun Y, Wu J, Wu B, Creamer AE, Gao B. Graphene oxide as filter media to remove levofloxacin and lead from aqueous solution. Chemosphere. 2016;150:759-764. DOI: 10.1016/j.chemosphere.2015.11.075
  81. 81. Liu FF, Zhao J, Wang S, Xing B. Adsorption of sulfonamides on reduced graphene oxides as affected by pH and dissolved organic matter. Environmental Pollution. 2016;210:85-93. DOI: 10.1016/j.envpol.2015.11.053
  82. 82. WHO. Worldwide strategy for the containment of antimicrobial resistance, WHO 2001. Available from:
  83. 83. USDA. Foreign Agricultural Service. Veterinary drug MRL database. Available from:
  84. 84. FAO/WHO. Available from:
  85. 85. Motarjemi Y, Lelieveld H. Fundamentals in management of food safety in the industrial setting: Challenges and outlook of the 21st century. In: Motarjemi Y, Lelieveld H, editors. Food Safety Management: A Practical Guide for the Food Industry. Academic Press; 2014. DOI: 10.1016/B978-0-12-381504-0.00001-9. Available from:
  86. 86. Commission Regulation 1353/2007/EC of 20th November, amending Council Regulation 2377/90/EC laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin. Official Journal, L 303
  87. 87. Hereber T, Lahrssen-Wiederholt M, Schafft H, Abraham K, Pzyrembel H, Henning KJ, et al. Zero tolerances in food and animal feed- are there any scientific alternatives? A European point of view of an international controversy. Toxicology Letters. 2007;175:118-135. DOI: 10.1016/j.toxlet.2007.10.002
  88. 88. Díaz-Álvarez M, Turiel E, Martín-Esteban A. Selective simple preparation for the analysis of (fluoro)quinolones in baby food: Molecularly imprinted polymers versus anion exchange resins. Analytical and Bioanalytical Chemistry. 2009;393:899-905. DOI: 10.1007/s00216-008-2300-9
  89. 89. Rodriguez E, Navarro Villoslada F, Moreno-Bondi MC, Marazuela MD. Optimization of a pressurized liquid extraction method by experimental design methodologies for the determination of fluoroquinolone residues in infant foods by liquid chromatography. Journal of Chromatography. A. 2010;1217:605-613. DOI: 10.1016/j.chroma.2009.11.089
  90. 90. Gentili A, Perret D, Marchese S, Sergi M, Olmi C, Curini R. Accelerated solvent extraction and confirmatory analysis of sulphonamide residues in raw meat and infant foods by liquid chromatography electrospray tandem mass spectrometry. Journal of Agricultural and Food Chemistry. 2004;52:4614-4624. DOI: 10.1021/jf0495690
  91. 91. Aguilera-Luiz MM, Martínez Vidal JL, Romero-González R, Garrido Frenich A. Multiclass method for fast determination of veterinary drug residues in baby food by ultra-high-performance liquid chromatography–tandem mass spectrometry. Food Chemistry. 2012;132:2171-2180. DOI: 10.1016/j.foodchem.2011.12.042
  92. 92. Moreno-González D, García-Campaña AM. Salting-out assisted liquid–liquid extraction coupled to ultra-high-performance liquid chromatography–tandem mass spectrometry for the determination of tetracycline residues in infant foods. Food Chemistry. 2017;221:1763-1769. DOI: 10.1016/j.foodchem.2016.10.107
  93. 93. He X, Wang GN, Yang K, Liu HZ, Wu XJ, Wang JP. Magnetic graphene dispersive solid phase extraction combining high performance liquid chromatography for determination of fluoroquinolones in foods. Food Chemistry. 2017;221:1226-1231. DOI: 10.1016/j.foodchem.2016.11.035
  94. 94. Xu J-J, An M, Yang R, Tan Z, Hao J, Cao J, et al. Determination of tetracycline antibiotic residues in honey and milk by miniaturized solid phase extraction using chitosan-modified graphitized multi-walled carbon nanotubes. Journal of Agricultural and Food Chemistry. 2016;64:2647-2654. DOI: 10.1021/acs.jafc.6b00748
  95. 95. Vakh C, Alaboud M, Lebedinets S, Korolev D, Postnov V, Moskvin L, et al. An automated magnetic dispersive micro-solid phase extraction in a fluidized reactor for the determination of fluoroquinolones in baby food samples. Analytica Chimica Acta. 2018;1001:59-69. DOI: 10.1016/j.aca.2017.11.065
  96. 96. Elazazy MS, Issa AA, Al-Mashreky M, Al-Sulaiti M, Al-Saad K. Application of fractional factorial design for green synthesis of cyano-modified silica nanoparticles: Chemometrics and multifarious response optimization. Advanced Powder Technology. 2018;29:1204-1215. DOI: 10.1016/j.apt.2018.02.012
  97. 97. Elazazy MS, Ganesh K, Sivakumar V, Huessein YHA. Interaction of p-synephrine with p-chloranil: Experimental design and multiple response optimization. RSC Advances. 2016;6:64967-64976. DOI: 10.1039/C6RA10533E
  98. 98. Elazazy MS. Determination of midodrine hydrochloride via Hantzsch condensation reaction: A factorial design based spectrophotometric approach. RSC Advances. 2015;5:48474-48483
  99. 99. Elazazy MS. Factorial design and machine learning strategies: Impacts on pharmaceutical analysis. In: Zafar F, editor. Spectroscopic Analyses. IntechOpen; 2017. DOI: 10.5772/intechopen.69891. Available from: analysis
  100. 100. Jia W, Chu X, Ling Y, Huang J, Chang J. High-throughput screening of pesticide and veterinary drug residues in baby food by liquid chromatography coupled to quadrupole Orbitrap mass spectrometry. Journal of Chromatography. A. 2014;1347:122-128. DOI: 10.1016/j.chroma.2014.04.081
  101. 101. Zhang B, Han X, Gu P, Fang S, Bai J. Response surface methodology approach for optimization of ciprofloxacin adsorption using activated carbon derived from the residue of desilicated rice husk. Journal of Molecular Liquids. 2017;238:316-325. DOI: 10.1016/j.molliq.2017.04.022

Written By

Ahmed El-Gendy, Ahmed S. El-Shafie, Ahmed Issa, Saeed Al-Meer, Khalid Al-Saad and Marwa El-Azazy

Submitted: October 15th, 2019 Reviewed: February 13th, 2020 Published: August 19th, 2020